Browsing by Author "Schalken, J.A."

Now showing items 1-50 of 312

Cost-effectiveness of SelectMDx for prostate cancer in four European countries: a comparative modeling study
Govers, T.M.; Hessels, Daphne; Vlaeminck-Guillem, Virginie; Schmitz-Draeger, Bernd J.; Stief, Christian G.; Martinez-Ballesteros, Claudio; Criekinge, W. van; Schalken, J.A.
2019, Article / Letter to editor (Prostate Cancer and Prostatic Diseases, vol. 22, iss. 1, (2019), pp. 101-109)
Adjuvant androgen deprivation therapy for poor-risk, androgen receptor-positive salivary duct carcinoma
Boxtel, W. van; Locati, L.D.; Engen-van Grunsven, A.C.H. van ; Bergamini, C.; Jonker, M.A.; Fiets, E.; Verhaegh, G.W. ; Schalken, J.A. ; Licitra, L.; Herpen, C.M.L. van
2019, Article / Letter to editor (European Journal of Cancer, vol. 110, (2019), pp. 62-70)
Genomic Markers in Prostate Cancer Decision Making
Cucchiara, V.; Cooperberg, M.R.; Dall'Era, M.; Lin, D.W.; Montorsi, F.; Schalken, J.A. ; Evans, C.P.
2018, Article / Letter to editor (European Urology, vol. 73, iss. 4, (2018), pp. 572-582)
Urine cell-based DNA methylation classifier for monitoring bladder cancer
Heijden, A.G. van der; Mengual, L.; Ingelmo-Torres, M.; Lozano, J.J.; Rijt-van de Westerlo, Cindy C.M. van; Baixauli, Montserrat; Schalken, J.A. ; Kiemeney, L.A.L.M. ; Witjes, J.A. ; Alcaraz, A.
2018, Article / Letter to editor (Clinical Epigenetics, vol. 10, (2018), article 71)
Epigenetic markers in circulating cell-free DNA as prognostic markers for survival of castration-resistant prostate cancer patients
Hendriks, R.J.; Dijkstra, S. ; Smit, F.P. ; Vandersmissen, Johan; Voorde, Hendrik Van de; Mulders, P.F.A. ; Oort, I.M. van ; Criekinge, W. van; Schalken, J.A.
2018, Article / Letter to editor (Prostate, vol. 78, iss. 5, (2018), pp. 336-342)
Development and Validation of a Bioanalytical Method to Quantitate Enzalutamide and its Active Metabolite N-Desmethylenzalutamide in Human Plasma: Application to Clinical Management of Patients With Metastatic Castration-Resistant Prostate Cancer
Benoist, G.E.; Meulen, E. van der; Oort, I.M. van ; Beumer, J.H.; Somford, D.M.; Schalken, J.A. ; Burger, D.M. ; Erp, N.P. van
2018, Article / Letter to editor (Therapeutic Drug Monitoring, vol. 40, iss. 2, (2018), pp. 222-229)
Consensus on molecular imaging and theranostics in prostate cancer
Fanti, S.; Minozzi, S.; Antoch, G.; Banks, I.; Briganti, A.; Carrio, I.; Chiti, A.; Clarke, N.; Eiber, M.; Bono, J. de; Fizazi, K.; Gillessen, S.; Gledhill, S.; Haberkorn, U.; Herrmann, K.; Hicks, R.J.; Lecouvet, F.; Montironi, R.; Ost, P.; O'Sullivan, J.M.; Padhani, A.R.; Schalken, J.A. ; Scher, H.I.; Tombal, B.; Moorselaar, R.J. van; Poppel, H. Van; Vargas, H.A.; Walz, J.; Weber, W.A.; Wester, H.J.; Oyen, W.J.G. et al. sine al.
2018, Article / Letter to editor (Lancet Oncology, vol. 19, iss. 12, (2018), pp. e696-e708)
A urine-based DNA methylation assay, ProCUrE, to identify clinically significant prostate cancer
Zhao, F.; Olkhov-Mitsel, E.; Kamdar, S.; Jeyapala, R.; Garcia, J.; Hurst, R.; Hanna, M.Y.; Mills, R.; Tuzova, A.V.; O'Reilly, E.; Kelly, S.; Cooper, C.; Brewer, D.; Perry, A.S.; Clark, J.; Schalken, J.A. ; Fleshner, N.; Bapat, B. et al. sine al.
2018, Article / Letter to editor (Clinical Epigenetics, vol. 10, iss. 1, (2018), pp. 147)
Label retention and stem cell marker expression in the developing and adult prostate identifies basal and luminal epithelial stem cell subpopulations
Ceder, J.A.; Aalders, T. ; Schalken, J.A.
2017, Article / Letter to editor (Stem Cell Research & Therapy, vol. 8, iss. 1, (2017), article 95)
Low PCA3 expression is a marker of poor differentiation in localized prostate tumors: exploratory analysis from 12,076 patients
Alshalalfa, M.; Verhaegh, G.W.C.T. ; Gibb, E.A.; Santiago-Jimenez, M.; Erho, N.; Jordan, J.; Yousefi, K.; Lam, L.L.C.; Kolisnik, T.; Chelissery, J.; Seiler, R.; Ross, A.E.; Karnes, R.J.; Schaeffer, E.M.; Lotan, T.T.; Den, R.B.; Freedland, S.J.; Davicioni, E.; Klein, E.A.; Schalken, J.A. et al. sine al.
2017, Article / Letter to editor (Oncotarget, vol. 8, iss. 31, (2017), pp. 50804-50813)
miRNA-520f Reverses Epithelial-to-Mesenchymal Transition by Targeting ADAM9 and TGFBR2
Kampen, J.G.M. van; Hooij, O. van ; Jansen, C.F.J. ; Smit, F.P. ; Noort, P.I.; Schultz, I.; Schaapveld, R.Q.J.; Schalken, J.A. ; Verhaegh, G.W.C.T.
2017, Article / Letter to editor (Cancer Research, vol. 77, iss. 8, (2017), pp. 2008-2017)
Urothelium update: how the bladder mucosa measures bladder filling
Janssen, D.A.W. ; Schalken, J.A. ; Heesakkers, J.P.F.A.
2017, Article / Letter to editor (Acta Physiologica, vol. 220, iss. 2, (2017), pp. 201-217)
Factors predicting progression to castrate-resistant prostate cancer in patients with advanced prostate cancer receiving long-term androgen-deprivation therapy
Taille, A. de la; Martinez-Pineiro, L.; Cabri, P.; Houchard, A.; Schalken, J.A.
2017, Article / Letter to editor (Bju International, vol. 119, iss. 1, (2017), pp. 74-81)
Molecular biomarkers to guide precision medicine in localized prostate cancer
Smits, M.; Mehra, N.; Sedelaar, M.; Gerritsen, W.R. ; Schalken, J.A.
2017, Article / Letter to editor (Expert Review of Molecular Diagnostics, vol. 17, iss. 8, (2017), pp. 791-804)
Blood-based and urinary prostate cancer biomarkers: a review and comparison of novel biomarkers for detection and treatment decisions
Hendriks, R.J.; Oort, I.M. van ; Schalken, J.A.
2017, Article / Letter to editor (Prostate Cancer and Prostatic Diseases, vol. 20, iss. 1, (2017), pp. 12-19)
A short-term intervention with selenium affects expression of genes implicated in the epithelial-to-mesenchymal transition in the prostate
Kok, D.E.; Kiemeney, L.A.L.M. ; Verhaegh, G.W.C.T. ; Schalken, J.A. ; Lin, E.N. van; Sedelaar, J.P.M. ; Witjes, J.A. ; Hulsbergen-van de Kaa, C.A. ; Veer, P. van 't; Kampman, E. ; Afman, L.A. et al. sine al.
2017, Article / Letter to editor (Oncotarget, vol. 8, iss. 6, (2017), pp. 10565-10579)
A urinary biomarker-based risk score correlates with multiparametric MRI for prostate cancer detection
Hendriks, R.J.; Leest, M.M.G. van der; Dijkstra, S. ; Barentsz, J.O. ; Criekinge, W. van; Kaa, C.A. van de ; Schalken, J.A. ; Mulders, P.F.A. ; Oort, I.M. van
2017, Article / Letter to editor (Prostate, vol. 77, iss. 14, (2017), pp. 1401-1407)
Cost-effectiveness of a new urinary biomarker-based risk score compared to standard of care in prostate cancer diagnostics - a decision analytical model
Dijkstra, S. ; Govers, T.M.; Hendriks, R.J.; Schalken, J.A. ; Criekinge, W. van; Neste, L. Van; Grutters, J.P.C.; Sedelaar, J.P.M. ; Oort, I.M. van
2017, Article / Letter to editor (Bju International, vol. 120, iss. 5, (2017), pp. 659-665)
Analytical challenges in quantifying abiraterone with LC-MS/MS in human plasma
Benoist, G.E.; Meulen, E. van der; Lubberman, F.J.E.; Gerritsen, W.R. ; Smilde, T.J. ; Schalken, J.A. ; Beumer, J.H.; Burger, D.M. ; Erp, N. van
2017, Article / Letter to editor (Biomedical Chromatography, vol. 31, iss. 11, (2017), article e3986)
Major milestones in translational oncology
Dragani, T.A.; Castells, A.; Kulasingam, V.; Diamandis, E.P.; Earl, H.; Iams, W.T.; Lovly, C.M.; Sedelaar, J.P.M. ; Schalken, J.A.
2016, Article / Letter to editor (BMC Medicine, vol. 14, iss. 1, (2016), pp. 110)
TRPV4 channels in the human urogenital tract play a role in cell junction formation and epithelial barrier.
Janssen, D.A.W. ; Jansen, CJ; Hafmans, T.G. ; Verhaegh, G.W. ; Hoenderop, J.G. ; Heesakkers, J.P. ; Schalken, J.A.
2016, Article / Letter to editor (Acta Physiologica, vol. 218, iss. 1, (2016), pp. 38-48)
XRP44X, an Inhibitor of Ras/Erk Activation of the Transcription Factor Elk3, Inhibits Tumour Growth and Metastasis in Mice
Semenchenko, K.; Wasylyk, C.; Cheung, H.; Tourrette, Y.; Maas, P.; Schalken, J.A. ; Pluijm, G. van der; Wasylyk, B.
2016, Article / Letter to editor (PLoS One, vol. 11, iss. 7, (2016), pp. e0159531)
TRPV4 mediates afferent pathways in the urinary bladder. A spinal c-fos study showing TRPV1 related adaptations in the TRPV4 knockout mouse.
Janssen, D.A.W. ; Hoenderop, J.G.J. ; Heesakkers, J.P.F.A. ; Schalken, J.A.
2016, Article / Letter to editor (Pflügers Archiv : European Journal of Physiology, vol. 468, iss. 10, (2016), pp. 1741-1749)
Enzalutamide: targeting the androgen signalling pathway in metastatic castration-resistant prostate cancer
Schalken, J.A. ; Fitzpatrick, J.M.
2016, Article / Letter to editor (Bju International, vol. 117, iss. 2, (2016), pp. 215-225)
Validatie van een nieuwe urinetest voor klinisch significante prostaatkanker.
Hendriks, R.; Dijkstra, S; Cornel, E.; Jannink, S.; Jong, H. de; Hessels, D.; Smit, F.; Melchers, W.J. ; Leyten, G.; Reijke, T. de; Vergunst, H.; Kil, P.; Knipscheer, B.; Hulsbergen-van de Kaa, C.A. ; Mulders, P. ; Oort, I. van; Schalken, J.A. et al. sine al.
2016, Article / Letter to editor (Tijdschrift voor Urologie, vol. 6, (2016), pp. 34-43)
A five-gene expression signature to predict progression in T1G3 bladder cancer
Heijden, A.G. van der; Mengual, L.; Lozano, J.J.; Ingelmo-Torres, M.; Ribal, M.J.; Fernandez, P.L.; Oosterwijk, E. ; Schalken, J.A. ; Alcaraz, A.; Witjes, J.A.
2016, Article / Letter to editor (European Journal of Cancer, vol. 64, (2016), pp. 127-136)
Comparative analysis of prostate cancer specific biomarkers PCA3 and ERG in whole urine, urinary sediments and exosomes
Hendriks, R.J.; Dijkstra, S. ; Jannink, S.A.; Steffens, M.G.; Oort, I.M. van ; Mulders, P.F.A. ; Schalken, J.A.
2016, Article / Letter to editor (Clinical Chemistry and Laboratory Medicine, vol. 54, iss. 3, (2016), pp. 483-492)
Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker-Based Risk Score.
Neste, L. Van; Hendriks, R.J.; Dijkstra, S. ; Trooskens, G.; Cornel, E.B.; Jannink, S.A.; Jong, H. de; Hessels, D.; Smit, F.P.; Melchers, W.J.G. ; Leyten, G.; Reijke, T.M. de; Vergunst, H.; Kil, P.; Knipscheer, B.C.; Kaa, C.A. van de ; Mulders, P.F.A. ; Oort, I.M. van ; Criekinge, W. van; Schalken, J.A. et al. sine al.
2016, Article / Letter to editor (European Urology, vol. 70, iss. 5, (2016), pp. 740-748)
Pharmacokinetic Aspects of the Two Novel Oral Drugs Used for Metastatic Castration-Resistant Prostate Cancer: Abiraterone Acetate and Enzalutamide
Benoist, G.E.; Hendriks, R.J.; Mulders, P.F. ; Gerritsen, W.R. ; Somford, D.M.; Schalken, J.A. ; Oort, I.M. van ; Burger, D.M. ; Erp, N. van
2016, Article / Letter to editor (Clinical Pharmacokinetics, vol. 55, iss. 11, (2016), pp. 1369-1380)
Direct dynamic measurement of intracellular and extracellular lactate in small-volume cell suspensions with (13)C hyperpolarised NMR
Breukels, V.; Jansen, K.F.J. ; Heijster, F.H.A. van; Capozzi, A.; Bentum, P.J. van; Schalken, J.A. ; Comment, A.; Scheenen, T.W.J.
2015, Article / Letter to editor (Nmr in Biomedicine, vol. 28, iss. 8, (2015), pp. 1040-1048)
Involvement of orphan nuclear receptor COUP-TFII in cadherin-6 and cadherin-11 regulation: implications in development and cancer
Bringuier, P.P.; Schalken, J.A. ; Hervieu, V.; Giroldi, L.A.
2015, Article / Letter to editor (Mechanisms of Development, vol. 136, (2015), pp. 64-72)
Contemporary approaches to prostate cancer management
Schalken, J.A. ; Westcott, G.
2015, Article / Letter to editor (Future Oncology, vol. 11, iss. 20, (2015), pp. 2735-2736)
The need for a personalized approach for prostate cancer management
Sedelaar, J.P.M. ; Schalken, J.A.
2015, Article / Letter to editor (BMC Medicine, vol. 13, (2015), pp. 109)
The role of the prostate cancer gene 3 urine test in addition to serum prostate-specific antigen level in prostate cancer screening among breast cancer, early-onset gene mutation carriers
Cremers, R.G.H.M. ; Eeles, R.A.; Bancroft, E.K.; Ringelberg-Borsboom, J.; Vasen, H.F.A.; Asperen, C.J. van; Schalken, J.A. ; Verhaegh, G.W.C.T. ; Kiemeney, L.A.L.M.
2015, Article / Letter to editor (Urologic Oncology-Seminars and Original Investigations, vol. 33, iss. 5, (2015), pp. 202.e19-28)
Genomic Predictors of Outcome in Prostate Cancer
Bostrom, P.J.; Bjartell, A.S.; Catto, J.W.; Eggener, S.E.; Lilja, H.; Loeb, S.; Schalken, J.A. ; Schlomm, T.; Cooperberg, M.R.
2015, Article / Letter to editor (European Urology, vol. 68, iss. 6, (2015), pp. 1033-1044)
The role of HOXC6 in prostate cancer development
Hamid, A.R.A.H.; Hoogland, A.M.; Smit, F.; Jannink, S.; Westerlo-van Rijt, C. van der; Jansen, C.F.J. ; Leenders, G.J. van; Verhaegh, G.W.C.T. ; Schalken, J.A.
2015, Article / Letter to editor (Prostate, vol. 75, iss. 16, (2015), pp. 1868-1876)
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015
Gillessen, S.; Omlin, A.; Attard, G.; Bono, J.S. de; Efstathiou, E.; Fizazi, K.; Halabi, S.; Nelson, P.S.; Sartor, O.; Smith, M.R.; Soule, H.R.; Akaza, H.; Beer, T.M.; Beltran, H.; Chinnaiyan, A.M.; Daugaard, G.; Davis, I.D.; Santis, M. de; Drake, C.G.; Eeles, R.A.; Fanti, S.; Gleave, M.E.; Heidenreich, A.; Hussain, M.; James, N.D.; Lecouvet, F.E.; Logothetis, C.J.; Mastris, K.; Nilsson, S.; Oh, W.K.; Olmos, D.; Padhani, A.R.; Parker, C.; Rubin, M.A.; Schalken, J.A. ; Scher, H.I.; Sella, A.; Shore, N.D.; Small, E.J.; Sternberg, C.N. ; Suzuki, H; Sweeney, C.J.; Tannock, I.F.; Tombal, B. et al. sine al.
2015, Article / Letter to editor (Annals of Oncology, vol. 26, iss. 8, (2015), pp. 1589-1604)
Identification of a Candidate Gene Panel for the Early Diagnosis of Prostate Cancer
Leyten, G.H.J.M.; Hessels, D.; Smit, F.P.; Jannink, S.A.; Jong, H. de; Melchers, W.J.G. ; Cornel, E.B.; Reijke, T.M. de; Vergunst, H.; Kil, P.; Knipscheer, B.C.; Hulsbergen-van de Kaa, C.A. ; Mulders, P.F. ; Oort, I.M. van ; Schalken, J.A. et al. sine al.
2015, Article / Letter to editor (Clinical Cancer Research, vol. 21, iss. 13, (2015), pp. 3061-3070)
Dutasteride and enzalutamide synergistically suppress prostate tumor cell proliferation
Hamid, A.R.; Verhaegh, G.W.C.T. ; Smit, F.P.; RIjt-van de Westerlo, C.; Armandari, I.; Brandt, A.; Sweep, C.G.J. ; Sedelaar, J.P.M. ; Schalken, J.A.
2015, Article / Letter to editor (Journal of Urology, vol. 193, iss. 3, (2015), pp. 1023-1029)
An update of the interstitial cell compartment in the normal human bladder
Kuijpers, K.A.J. ; Heesakkers, J.P.F.A. ; Hafmans, T.G.M. ; Schalken, J.A.
2014, Article / Letter to editor (Biomed Research International, vol. 2014, (2014), pp. 464217)
Noncoding RNAs as Novel Biomarkers in Prostate Cancer
Ronnau, C.G.; Verhaegh, G.W.C.T. ; Luna-Velez, M.V.; Schalken, J.A.
2014, Article / Letter to editor (Biomed Research International, vol. 2014, (2014), pp. 591703)
Alterations of the myovesical plexus of the human overactive detrusor
Kuijpers, K.A.J. ; Heesakkers, J.P.F.A. ; Schalken, J.A.
2014, Article / Letter to editor (Biomed Research International, vol. 2014, (2014), pp. 754596)
Intratumoral steroidogenesis in castration-resistant prostate cancer: a target for therapy
Armandari, I.; Hamid, A.R.A.H.; Verhaegh, G.; Schalken, J.A.
2014, Article / Letter to editor (Prostate International, vol. 2, iss. 3, (2014), pp. 105-113)
Three-dimensional models of cancer for pharmacology and cancer cell biology: capturing tumor complexity in vitro/ex vivo
Hickman, J.A.; Graeser, R.; Hoogt, R. de; Vidic, S.; Brito, C.; Gutekunst, M.; Kuip, H. van der; Schalken, J.A. ; et al.
2014, Article / Letter to editor (Biotechnology Journal, vol. 9, iss. 9, (2014), pp. 1115-1128)
Evaluation of urinary prostate cancer antigen-3 (PCA3) and TMPRSS2-ERG score changes when starting androgen-deprivation therapy with triptorelin 6-month formulation in patients with locally advanced and metastatic prostate cancer
Martinez-Pineiro, L.; Schalken, J.A. ; Cabri, P.; Maisonobe, P.; Taille, A. De La; Study, G.
2014, Article / Letter to editor (Bju International, vol. 114, iss. 4, (2014), pp. 608-616)
Prevention and early detection of prostate cancer
Cuzick, J.; Thorat, M.A.; Andriole, G.; Brawley, O.W.; Brown, P.H.; Culig, Z.; Eeles, R.A.; Ford, L.G.; Hamdy, F.C.; Holmberg, L.; Ilic, D.; Key, T.J.; Vecchia, C. La; Lilja, H.; Marberger, M.; Meyskens, F.L.; Minasian, L.M.; Parker, C.; Parnes, H.L.; Perner, S.; Rittenhouse, H.; Schalken, J.A. ; Schmid, H.P.; Schmitz-Drager, B.J.; Schroder, F.H.; Stenzl, A.; Tombal, B.; Wilt, T.J.; Wolk, A. et al. sine al.
2014, Article / Letter to editor (Lancet Oncology, vol. 15, iss. 11, (2014), pp. e484-92)
Clinical use of novel urine and blood based prostate cancer biomarkers: a review
Dijkstra, S. ; Mulders, P.F.A. ; Schalken, J.A.
2014, Article / Letter to editor (Clinical Biochemistry, vol. 47, iss. 10-11, (2014), pp. 889-896)
Prospective multicentre evaluation of PCA3 and TMPRSS2-ERG gene fusions as diagnostic and prognostic urinary biomarkers for prostate cancer
Leyten, G.H.J.M.; Hessels, D. ; Jannink, S.A. ; Smit, F.P. ; Jong, H. de ; Cornel, E.B. ; Reijke, T.M. de; Vergunst, H.; Kil, P.; Knipscheer, B.C. ; Oort, I.M. van ; Mulders, P.F.A. ; Hulsbergen-van de Kaa, C.A. ; Schalken, J.A. et al. sine al.
2014, Article / Letter to editor (European Urology, vol. 65, iss. 3, (2014), pp. 534-542)
Prostate cancer biomarker profiles in urinary sediments and exosomes
Dijkstra, S. ; Birker, I.L.; Smit, F.P. ; Leyten, G.H.J.M.; Reijke, T.M. de; Oort, I.M. van ; Mulders, P.F.A. ; Jannink, S.A. ; Schalken, J.A.
2014, Article / Letter to editor (Journal of Urology, vol. 191, iss. 4, (2014), pp. 1132-1138)
KLK3, PCA3, and TMPRSS2-ERG expression in the peripheral blood mononuclear cell fraction from castration-resistant prostate cancer patients and response to docetaxel treatment
Dijkstra, S. ; Leyten, G.H.J.M.; Jannink, S.A. ; Jong, H. de ; Mulders, P.F.A. ; Oort, I.M. van ; Schalken, J.A.
2014, Article / Letter to editor (Prostate, vol. 74, iss. 12, (2014), pp. 1222-1230)

Now showing items 1-50 of 312

Search Repository

Browse

All of Repository

Radboud Repository

Browsing by Author "Schalken, J.A."

Search Repository

Browse

All of Repository